» Articles » PMID: 38965543

The Clinical Impact of Estimating Low-density Lipoprotein Cholesterol (LDL-C) Using Different Equations in the General Population

Abstract

Background: Low-density lipoprotein cholesterol (LDL-C) is associated with atherosclerotic cardiovascular disease (ASCVD). Friedewald, Sampson, and Martin-Hopkins equations are used to calculate LDL-C. This study compares the impact of switching between these equations in a large geographically defined population.

Materials And Methods: Data for individuals who had a lipid panel ordered clinically between 2010 and 2019 were included. Comparisons were made across groups using the two-sample t-test or chi-square test as appropriate. Discordances between LDL measures based on clinically actionable thresholds were summarized using contingency tables.

Results: The cohort included 198,166 patients (mean age 54 years, 54% female). The equations perform similarly at the lower range of triglycerides but began to diverge at a triglyceride level of 125 mg/dL. However, at triglycerides of 175 mg/dL and higher, the Martin-Hopkins equation estimated higher LDL-C values than the Samson equation. This discordance was further exasperated at triglyceride values of 400 to 800 mg/dL. When comparing the Sampson and Friedewald equations, at triglycerides are below 175 mg/dL, 9% of patients were discordant at the 70 mg/dL cutpoint, whereas 42.4% were discordant when triglycerides are between 175 and 400 mg/dL. Discordance was observed at the clinically actionable LDL-C cutpoint of 190 mg/dL with the Friedewald equation estimating lower LDL-C than the other equations. In a high-risk subgroup (ASCVD risk score > 20%), 16.3% of patients were discordant at the clinical cutpoint of LDL-C < 70 mg/dL between the Sampson and Friedewald equations.

Conclusions: Discordance at clinically significant LDL-C cutpoints in both the general population and high-risk subgroups were observed across the three equations. These results show that using different methods of LDL-C calculation or switching between different methods could have clinical implications for many patients.

References
1.
Azimi V, Farnsworth C, Roper S . Comparison of the Friedewald equation with Martin and Sampson equations for estimating LDL cholesterol in hypertriglyceridemic adults. Clin Biochem. 2022; 108:1-4. DOI: 10.1016/j.clinbiochem.2022.07.005. View

2.
Goff Jr D, Lloyd-Jones D, Bennett G, Coady S, DAgostino R, Gibbons R . 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2013; 129(25 Suppl 2):S49-73. DOI: 10.1161/01.cir.0000437741.48606.98. View

3.
Shi B, Wang H, Liu J, Cai Z, Song C, Jia L . Directly Measured vs. Calculated Low-Density Lipoprotein Cholesterol Does Not Identify Additional Individuals With Coronary Artery Disease and Diabetes at Higher Risk of Adverse Events: Insight From a Large Percutaneous Coronary Intervention Cohort.... Front Cardiovasc Med. 2022; 9:932878. PMC: 9301080. DOI: 10.3389/fcvm.2022.932878. View

4.
Sajja A, Li H, Spinelli K, Blumenthal R, Virani S, Martin S . Discordance Between Standard Equations for Determination of LDL Cholesterol in Patients With Atherosclerosis. J Am Coll Cardiol. 2022; 79(6):530-541. DOI: 10.1016/j.jacc.2021.11.042. View

5.
Martin S, Blaha M, Elshazly M, Toth P, Kwiterovich P, Blumenthal R . Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile. JAMA. 2013; 310(19):2061-8. PMC: 4226221. DOI: 10.1001/jama.2013.280532. View